Trial intelligence / Profile preview

Vinorelbine, capecitabine, and paclitaxel as first-line therapy in metastatic breast cancer pretreated with adjuvant anthracyclines

2005-005683-87Phase 2Active

Sponsor
San Luigi Gonzaga Hospital
Start
Jan 2006
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of vinorelbine, capecitabine, paclitaxel in breast cancer, sponsored by San Luigi Gonzaga Hospital. Started Jan 2006; status: active.

02

Drugs

vinorelbinecapecitabinepaclitaxel
03

Conditions

breast cancer

Beyond the preview

Go deeper on 2005-005683-87.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005683-87.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call